INNOVATION PHARMACEUTICALS INC. Interest Expense, Other
INNOVATION PHARMACEUTICALS INC. reported Interest Expense, Other of $52.00 thousand for the 12-month period ending 2020-06-30, per its 10-K filed 2020-09-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseOther · last filed 2020-09-14
- INNOVATION PHARMACEUTICALS INC. interest expense, other for the quarter ending 2020-06-30 was $103.00K, a 97.42% decline year-over-year.
- INNOVATION PHARMACEUTICALS INC. interest expense, other for the quarter ending 2020-03-31 was -$11.00K.
- INNOVATION PHARMACEUTICALS INC. interest expense, other for the quarter ending 2019-12-31 was -$20.00K.
- INNOVATION PHARMACEUTICALS INC. interest expense, other for the quarter ending 2019-09-30 was -$20.00K.
- INNOVATION PHARMACEUTICALS INC. interest expense, other for fiscal 2020 was $52.00K, a 97.40% decline from fiscal 2019.
- INNOVATION PHARMACEUTICALS INC. interest expense, other for fiscal 2019 was $2.00M.
| Period end | Interest Expense, Other 3 month | Interest Expense, Other 6 month | Interest Expense, Other 6 month as first filed | Interest Expense, Other 9 month | Interest Expense, Other 9 month as first filed | Interest Expense, Other 12 month |
|---|---|---|---|---|---|---|
| 2020-06-30 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-14 | $92.00K derived: sum of 2 quarters · filed 2020-09-14 | $72.00K derived: sum of 3 quarters · filed 2020-09-14 | $52.00K 10-K · filed 2020-09-14 | ||
| 2020-03-31 | -$11.00K 10-Q · filed 2020-05-14 | -$31.00K derived: sum of 2 quarters · filed 2020-05-14 | -$51.00K 10-Q · filed 2020-05-14 | $3.94M derived: sum of 4 quarters · filed 2020-09-14 | ||
| 2019-12-31 | -$20.00K 10-Q · filed 2020-02-13 | -$40.00K 10-Q · filed 2020-02-13 | $3.95M derived: sum of 3 quarters · filed 2020-09-14 | $3.94M derived: sum of 4 quarters · filed 2020-09-14 | ||
| 2019-09-30 | -$20.00K derived: 10-K 12 month − 3 quarters · filed 2020-09-14 | $3.97M derived: sum of 2 quarters · filed 2020-09-14 | $3.96M derived: sum of 3 quarters · filed 2020-09-14 | $1.98M derived: sum of 4 quarters · filed 2020-09-14 | ||
| 2019-06-30 | $3.99M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-14 | $3.98M derived: sum of 2 quarters · filed 2020-09-14 | $2.00M derived: sum of 3 quarters · filed 2020-09-14 | $2.00M 10-K · filed 2020-09-14 | ||
| 2019-03-31 | -$15.00K 10-Q · filed 2020-05-14 | -$1.99M derived: sum of 2 quarters · filed 2020-05-14 | -$1.99M 10-Q · filed 2020-05-14 | $1.99M 10-Q · filed 2019-05-10 | ||
| 2018-12-31 | -$1.98M 10-Q · filed 2020-02-13 | -$1.98M 10-Q · filed 2020-02-13 | $1.98M 10-Q · filed 2019-02-08 |